Management of the Virulent Influenza Virus Infection by Oral Formulation of Nonhydrolized Carnosine and Isopeptide of Carnosine Attenuating Proinflammatory Cytokine-Induced Nitric Oxide Production : American Journal of Therapeutics

Secondary Logo

Journal Logo

Therapeutic Review

Management of the Virulent Influenza Virus Infection by Oral Formulation of Nonhydrolized Carnosine and Isopeptide of Carnosine Attenuating Proinflammatory Cytokine-Induced Nitric Oxide Production

Babizhayev, Mark A PhD1,2*; Deyev, Anatoly I PhD1

Author Information
American Journal of Therapeutics 19(1):p e25-e47, January 2012. | DOI: 10.1097/MJT.0b013e3181dcf589

Abstract

© 2012 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid